Chemoinformaics analysis of Methyl tetradecanoate
| Molecular Weight | 242.403 | nRot | 12 |
| Heavy Atom Molecular Weight | 212.163 | nRig | 4 |
| Exact Molecular Weight | 242.225 | nRing | 0 |
| Solubility: LogS | -6.345 | nHRing | 0 |
| Solubility: LogP | 6.795 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 47 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 30 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 46.6578 |
| nHD | 0 | BPOL | 32.7002 |
| QED | 0.303 |
| Synth | 2.84 |
| Natural Product Likeliness | 1.524 |
| NR-PPAR-gamma | 0.534 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.002 |
| HIA | 0.004 |
| CACO-2 | -4.553 |
| MDCK | 0.000012 |
| BBB | 0.261 |
| PPB | 0.973814 |
| VDSS | 1.422 |
| FU | 0.0245004 |
| CYP1A2-inh | 0.965 |
| CYP1A2-sub | 0.161 |
| CYP2c19-inh | 0.663 |
| CYP2c19-sub | 0.064 |
| CYP2c9-inh | 0.674 |
| CYP2c9-sub | 0.931 |
| CYP2d6-inh | 0.251 |
| CYP2d6-sub | 0.887 |
| CYP3a4-inh | 0.767 |
| CYP3a4-sub | 0.082 |
| CL | 8.74 |
| T12 | 0.181 |
| hERG | 0.003 |
| Ames | 0.08 |
| ROA | 0.003 |
| SkinSen | 0.979 |
| Carcinogencity | 0.188 |
| EI | 0.992 |
| Respiratory | 0.383 |
| NR-Aromatase | 0.058 |
| Antiviral | Yes |
| Prediction | 0.75708 |